Publications – Efferon

Critical Care 2024, 28(Suppl 1):P220

Hemoperfusion with Efferon LPS NEO device reverts multiple organ failure, decreases IL-6 and TNF levels and systemic immune inflammation in children with sepsis

SM Stepanenko, II Afukov, YS Aleksandrovich, EV Zilbert, AB Chatchukhina, IV Turischev, MA Rusak, AL Shavkin, AY Popov, VM Pisarev

Shock. 2023 Jun 1;59(6):846-854

Hemoperfusion using the LPS-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trial

Rey, S; Kulabukhov, V.; Popov, A; Nikitina, O; Berdnikov, G; Magomedov, M; Kim, T; Masolitin, S; Ignatenko, O; Krotenko, N; Marysheva, A; Chaus, N; Ohinko, L; Mendibaev, M; Chumachenko, A; Pisarev, V*.

Intensive Care Medicine Experimental 2022, 10(2): 000710

Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinflammatory biomarkers in patients with intra-abdominal sepsis

M. Magomedov; TG. Kim; SV. Masolitin; V. Pisarev

Critical Care 2021, 25(Suppl 1): P041

Hemoperfusion with the Efferon CT extracorporeal adsorbers containing mesoporous styrene–divinylbenzene copolymer (SDC) in patients with severe COVID-19

M. Magomedov, T. Kim, S. Masolitin, A. Yaralian, E. Kalinin, V. Pisarev

World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.

Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock

M.I. Gromov, L.P. Pivovarova, I.V. Osipova, O.B. Ariskina, A.V. Fedorov

Therapeutic archive. 2021; 93 (7): 811-817

Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation

Shchekina A.E., Galstyan G.M., Gavrilina O.A., Arapova N.M., Bronyakina S.Yu., Kotova E.S., Troitskaya V.V., Parovichnikova E.N., Maschan M A., Savchenko V.G.